Want a COVID vaccine? It could cost you $200. Trump administration COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay out of pocket, including pregnant ...

After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there’s new confusion and uncertainty about who can get the shots — and ...

The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.

A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as recent moves by the Trump administration threaten to make vaccines harder ...

Long covid patients are desperate for treatments. These trials may help. Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines and treatments, why are people still dying?

As promised, federal health officials this week dropped longstanding recommendations that healthy children and healthy pregnant women should get the COVID-19 vaccines.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots ...